PEComas are distinguished by the expression of smooth muscle markers (e.g., SMA, h-caldesmon, desmin) and melanocytic markers (e.g., HMB-45, melan-A, MITF). This evidence concerns the gene DES and neoplasm with perivascular epithelioid cell differentiation.